BAG3 (BCL2-associated athanogene 3) knockdown is known to affect proliferation, migration, and invasion of EGFR-positive triple-negative breast cancer cell lines via AKT and FAK kinases (47). The gene discussed is EGFR; the disease is triple-negative breast carcinoma.